Athanasios Papakyriakou

25PUBLICATIONS
67CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Electrical energy generation (incl. renewables, excl. photovoltaics)Molecular targetsMedical roboticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 27, 2026
Design, Synthesis, Antiproliferative Potency and In Silico Studies of Novel Alkynyl Quinazolines as Potential EGFR Inhibitors.

Apostolia Gkoutzivelaki, Sotiria-Iro Triantopoulou, Lykourgos Chiniadis

|Sep 17, 2025
Specific targeting of transcriptional T-box riboswitches leads to effective inhibition of S. aureus.

Nikoleta Giarimoglou, Adamantia Kouvela, Athanasios Papakyriakou

|May 12, 2025
Discovery of Novel Allosteric Inhibitor Hits for Insulin-Regulated Aminopeptidase Provides Insights on Enzymatic Mechanism.

Galateia Georgaki, Nikoletta-Maria Koutroumpa, Panagiotis Lagarias

|Feb 13, 2025
BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating Triglycerides.

Xenophon Asvos, Mohamed A El Mubarak, Theodoros Karampelas

Pageof 5